New research from a University of Cincinnati Cancer Center study found external beam radiation therapy (EBRT) is safe to ...
A prospective, multicenter phase 2 trial evaluated the safety of neoadjuvant radiation plus immunotherapy before radical cystectomy for bladder cancer.
Imaging suggests HCC, yet cirrhosis is uncertain—see why biopsy matters and how AFP, spread, and liver function shape treatment. For oncology clinicians, the Liver Imaging-Reporting and Data System ...
More than one-fifth of individuals with HCC experience treatment delays exceeding 90 days, but those delays do not significantly affect overall survival.
The University of Missouri and MU Health Care recently started a first round of in-person trials of a new cancer treatment. The School of Medicine, ABK Biomedical and the University of Missouri ...
The National Cancer Institute, the federal research agency charged with leading the war against the nation’s second-largest killer, is studying ivermectin as a potential cancer treatment, according to ...
Prof. Terence Lee, Associate Head and Professor of the PolyU Department of Applied Biology and Chemical Technology, and his research team have developed a novel antibody targeting the ...
Delivering cancer immunotherapy earlier in the day really could extend survival, according to the first randomised-controlled trial into how the timing of such interventions affects patient outcomes.
Mark Burkholder tells PEOPLE he and his late wife, Paige, wanted to document the "raw and honest" reality of terminal cancer Cara Lynn Shultz is a writer-reporter at PEOPLE. Her work has previously ...
The medication is really taking care of business. A pair of new Canadian clinical trials show poop pills can reduce the toxic side effects of cancer medications and even support patient response to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results